A detailed history of Mondrian Investment Partners LTD transactions in Novartis Ag stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 1,000,159 shares of NVS stock, worth $97.1 Million. This represents 1.92% of its overall portfolio holdings.

Number of Shares
1,000,159
Previous 1,272,482 21.4%
Holding current value
$97.1 Million
Previous $135 Million 15.08%
% of portfolio
1.92%
Previous 2.35%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$106.13 - $120.89 $28.9 Million - $32.9 Million
-272,323 Reduced 21.4%
1,000,159 $115 Million
Q2 2024

Aug 12, 2024

SELL
$92.57 - $107.37 $73.4 Million - $85.2 Million
-793,257 Reduced 38.4%
1,272,482 $135 Million
Q1 2024

May 07, 2024

BUY
$95.27 - $108.47 $56.3 Million - $64.1 Million
590,830 Added 40.06%
2,065,739 $200 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $74.8 Million - $82.3 Million
810,282 Added 121.92%
1,474,909 $149 Million
Q2 2023

Sep 20, 2023

SELL
$92.52 - $104.91 $2.13 Million - $2.41 Million
-23,000 Reduced 3.34%
664,627 $67.1 Million
Q1 2023

Sep 20, 2023

BUY
$80.03 - $92.81 $1.84 Million - $2.13 Million
23,000 Added 3.46%
687,627 $63.3 Million
Q1 2023

May 09, 2023

SELL
$80.03 - $92.81 $320,120 - $371,240
-4,000 Reduced 0.58%
687,627 $63.3 Million
Q4 2022

Feb 03, 2023

SELL
$75.55 - $92.52 $4.38 Million - $5.37 Million
-58,000 Reduced 7.74%
691,627 $62.7 Million
Q3 2022

Oct 21, 2022

SELL
$74.61 - $87.26 $3.59 Million - $4.19 Million
-48,071 Reduced 6.03%
749,627 $57 Million
Q2 2022

Aug 09, 2022

SELL
$80.52 - $93.75 $5.56 Million - $6.47 Million
-69,000 Reduced 7.96%
797,698 $67.4 Million
Q1 2022

May 05, 2022

BUY
$80.11 - $90.62 $4.81 Million - $5.44 Million
60,000 Added 7.44%
866,698 $76.1 Million
Q4 2021

Feb 09, 2022

BUY
$79.7 - $88.13 $13.8 Million - $15.3 Million
173,188 Added 27.34%
806,698 $70.6 Million
Q1 2021

May 10, 2021

BUY
$83.5 - $98.47 $15.4 Million - $18.1 Million
184,093 Added 40.96%
633,510 $54 Million
Q4 2020

Feb 11, 2021

SELL
$78.07 - $94.43 $518,150 - $626,731
-6,637 Reduced 1.46%
449,417 $42.4 Million
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $255,291 - $282,828
3,108 Added 0.69%
456,054 $35.6 Million
Q2 2020

Aug 10, 2020

BUY
$80.93 - $91.1 $292,400 - $329,144
3,613 Added 0.8%
452,946 $39.6 Million
Q1 2020

May 12, 2020

SELL
$70.67 - $99.01 $3.75 Million - $5.25 Million
-53,000 Reduced 10.55%
449,333 $37 Million
Q4 2018

Jan 24, 2019

SELL
$73.66 - $82.02 $3.39 Million - $3.77 Million
-46,000 Reduced 8.39%
502,333 $43.1 Million
Q1 2018

May 11, 2018

SELL
$70.39 - $84.15 $427,408 - $510,958
-6,072 Reduced 1.1%
548,333 $42.1 Million
Q3 2017

Nov 02, 2017

BUY
$74.14 - $77.27 $41.1 Million - $42.8 Million
554,405
554,405 $47.6 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mondrian Investment Partners LTD Portfolio

Follow Mondrian Investment Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mondrian Investment Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mondrian Investment Partners LTD with notifications on news.